Intrafamilial phenotypic variability of Hallervorden-Spatz syndrome in a Tunisian family

Parkinsonism and Related Disorders

Volumn 6, Issue 3, 2000, Pages 175-179

  Gouider Khouja, N ^a   Miladi, N ^a   Belal, S ^a   Hentati, F ^a  

^a Institut National de Neurologie Tunisia   (Tunisia)

Author keywords

Dystonia; Hallervorden Spatz syndrome; MRI; Psychosis

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELUSION; DISEASE COURSE; DYSARTHRIA; DYSTONIA; EPILEPSY; FAMILY STUDY; FEMALE; HALLERVORDEN SPATZ DISEASE; HALLUCINATION; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RETINA DEGENERATION; TREMOR;

EID: 0034097293     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(99)00060-7     Document Type: Article

References (23)

1. Hallervorden J., Spatz H. Eigenartige Erkrankgung im extrapyramidalem system mit besonderer beteilgung des globus pallidus und der substantia nigra. Ges Neurol Psychiat. 79:1923;254-302.
2. Dooling E.C., Schoene W.C., Richardson E.P. Hallervorden-Spatz syndrome. Arch Neurol. 30:1974;70-83.
3. Sethi K.D., Adams R.J., Loring D.W., El Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol. 24:1988;692-694.
4. Ostergaard J.R., Christensen T., Hansen K.N. In vivo diagnosis of Hallervorden-Spatz disease. Dev Med Child Neurol. 37:1995;827-833.
5. Halliday W. The nosology of Hallervorden-Spatz disease. J Neurol Sci. 134:1995;84-91. (Suppl).
6. Jankovic J., Kirkpatrick J.B., Blomquist K.A., Langlais P.J., Bird E.D. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology. 35:1985;227-234.
7. Higgins J.J., Patterson M.C., Papadopoulos N.M., Brady R.O., Pentchev P.G., Barton N.W. Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome). Neurology. 42:1992;194-198.
8. Tripathi C., Tripathi B.J., Bauserman S.C., Park J.K. Clinico-pathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome. Acta Neuropathol. 83:1992;113-119.
9. 59Fe-uptake in basal ganglia: Hallervorden-Spatz disease or ceroid storage disease with abnormal isotope scan. Neurology. 33:1983;301-305.
10. Orrell R.W., Amrolia P.J., Heald A., Cleland P.G., Owen J.S., Morgan-Hughes J.A., Harding A.E., Marsden C.D. Acanthocytosis, retinitis pigmentosa and pallidal degeneration. A report of three patients, including the second reported case with hypo-prebetalipoproteinemia (HARP syndrome). Neurology. 45:1995;487-492.
11. Eidelberg D., Sotrel A., Joachim C., Selkoe D., Forman A., Pendelburg W.N., Perl D.P. Adult onset Hallervorden-Spatz disease with neurofibrilary pathology. Brain. 110:1987;993-1013.
12. Alberca R., Rafel E., Chinchar I., Vadilla J., Navarro A. Late onset Parkinsonian syndrome in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiat. 50:1987;1665-1668.
13. Dooling E.C., Richardson E.P., Davis K.R. Computed tomography in Hallervorden-Spatz disease. Neurology. 30:1980;1128-1130.
14. Vankirk M.P., Larsen P.D., O'Connor P.S. New computed tomography scan finding in Hallervorden-Spatz syndrome. J Clin Neuro Ophtalmol. 6:1986;86-88.
15. Bolthauser E., Lang W., Janzer R., Briner J., Spiess H., Kleihues P., Isler W. Computed tomography in Hallervorden-Spatz disease. Neuropediatrics. 38:1996;934-938.
16. Tennison M.B., Bouldin T.W., Whaley R.A. Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome. Neurology. 38:1988;154-155.
17. Johnson M.A., Pennock J.M., Bydder G.M., et al. Clinical and MR imaging of the brain in children: normal and neurologic disease. Am J Roentgenol. 141:1983;1005-1018.
18. Littrup P.J., Gerbarski S.S. MR imaging of Hallervorden-Spatz disease. J comput Assist Tomogr. 9:1985;491-493.
19. Rutledge J.N., Hilar S.K., Silver A.J., Defendini R., Fahn S. Study of movement disorder and brain iron by magnetic resonance. Am J Neuroradiol. 8:1987;397-412.
20. Schaffert D.A., Johnson S.D., Johnson P.C., Drayer B.P. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Neurology. 39:1989;440-442.
21. Angelini L., Nardocci N., Rumi V., Zorzi C., Strada L., Savoiardo M. Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life. J Neurol. 239:1992;417-425.
22. Swaiman K.F. Hallervorden Spatz syndrome. Neurobase. 3/98:1998.
23. Taylor T.D., Litt M., Kramer P., Pandolfo M., Angelini L., Nardocci N., Davis S., Pineda M., Mattori M., Flett P.J., Cilio M.R., Bertini E., Hayflick S.J. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nature Genet. 14:(4):1996;479-481.